河南省脑靶向生物纳米药物重点实验室
  河南省纳米生物医学国际联合实验室
 
当前位置: 首页/科研成果/文章/2021/正文
 

Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy.

Y. Sun, Q. Yang, X. Xia, X. Li, W. Ruan, M. Zheng, Y. Zou*, B. Shi.*

Frontiers in Bioengineering and Biotechnology 2021, 9, 755727.(IF=6.064)


Despite all sorts of innovations in medical researches over the past decades, cancer remains a major threat to human health. Mitochondria are essential organelles in eukaryotic cells, and their dysfunctions contribute to numerous diseases including cancers. Mitochondria-targeted cancer therapy, which specifically delivers drugs into the mitochondria, is a promising strategy for enhancing anticancer treatment efficiency. However, owing to their special double-layered membrane system and highly negative potentials, mitochondria remain a challenging target for therapeutic agents to reach and access. Polymeric nanoparticles exceed in cancer therapy ascribed to their unique features including ideal biocompatibility, readily design and synthesis, as well as flexible ligand decoration. Significant efforts have been put forward to develop mitochondriatargeted polymeric nanoparticles. In this review, we focused on the smart design of polymeric nanosystems for mitochondria targeting and summarized the current applications in improving cancer therapy.

2C3812





  地址
河南省开封市
河南大学金明校区,生命科学学院
475004
 技术支持:河南科加
  联系方式
邮箱: jcbi@vip.henu.edu.cn
facebooktwitteryoutubeg+